Clinical trials recruiting for Small Cell Lung Cancer Limited Stage
3
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Adebrelimab | 1 |
| Apatinib Mesylate | 1 |
| Carboplatin | 1 |
| Etoposide | 1 |
| Induction Durvalumab +etoposide/platinum +Radiochemotherapy+ durvalumab maintenance | 1 |
Self-screener
Recruiting trials
- A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer
- Durvalumab as Consolidation for Patients LS-SCLC
- Molecular Analysis and Treatment Options of SCLC
Related conditions
Trials recruiting for Small Cell Lung Cancer Limited Stage often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Small Cell Lung Carcinoma 20Small Cell Lung Cancer Extensive Stage 14Small cell lung cancer 87
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Small Cell Lung Cancer Limited Stage trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.